A REAL-LIFE EXPERIENCE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATMENT

  • Alice Cristina PAVEL Pneumology Clinical Hospital Iasi, Romania
  • Elena COJOCARU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Ruxandra-Mioara RAJNOVEANU “Iuliu Hațieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania
  • C. COJOCARU “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Abstract

Chronic Obstructive Pulmonary Disease (COPD) is an important public health problem, generating costs for treatment, hospitalization, and decrease work capacity. Aim: A cohort of patients was followed in a prospective study for a better understanding of the practical difficulties in management of the COPD patients from Iasi County. In order to evaluate these patients, we collected data regarding smoke status, inhalation technique, therapy changes. The periodic medication update, the assessment of the inhalation technique, the developing and increasing access to respiratory rehabilitation centers will work to improve COPD patients’ quality of life and to ensure quality of medical services. Results: The distribution of patients on risk classes indicates a higher proportion of these in classes D and B. Of the total patients evaluated 12 (32.4%) have correctly used the inhaler device, while 25 patients (67.6%) made at least one mistake: 15 patients (40.5%) did not forcefully expire before using the device, 6 (16.2%) did not inspire enough, four (12%) had trouble in maintaining apnea. A high proportion of patients were treated with the inhaled corticosteroids + long-acting beta2-agonistis therapy (56.8%), 64.9% of the patients were treated with inhaled corticosteroids. Conclusions: Although there are many interventions recommended in patients with COPD, too few interventions are included in practice for a better disease control.

Author Biographies

Alice Cristina PAVEL, Pneumology Clinical Hospital Iasi, Romania

Clinic of Pulmonary Diseases

Elena COJOCARU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Morpho-functional Sciences (II)

Ruxandra-Mioara RAJNOVEANU, “Iuliu Hațieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania

Clinic of Pulmonary Diseases, Cluj-Napoca, Romania

C. COJOCARU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Department of Medical Specialties (III)

References

1. Kim J, Lee TJ, Kim S, Lee E. The economic burden of chronic obstructive pulmonary disease from 2004 to 2013. J Med Econ 2016; 19: 103-110.
2. ***GOLD. Gold 2017. Glob Inititiative Chronic Obstr Lung Dis 2017: 1-139.
3. Kocks J, Chrystyn H, van der Palen J, et al. Systematic review of association between critical errors in inhalation and health outcomes in asthma and COPD. NPJ Prim Care Respir Med 2018; 16: 43.
4. Jones PW, Nadeau G, Small M, Adamek L. Characteristics of a COPD population categorized using the GOLD framework by health status and exacerbations. Respir Med 2014; 108: 129-135.
5. Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: A study of the general population. Am J Respir Crit Care Med 2012; 186: 975-981.
6. Trofor L, Marginean C, Man M, Miron R, Barnea E, Trofor AC. Smoking cessation for free: First long-term outcomes in three Romanian centers. Eur Respir Journal Conf Eur Respir Soc Annu Congr. 2015; 46.
7. Peiffer G, Underner M, Perriot J. COPD and smoking cessation: Patients’ expectations and responses of health professionals. Revue de Pneumologie Clinique 2018; 74: 375-390.
8. Price D, West D, Brusselle G, et al. Management of COPD in the UK primary-care setting: An analysis of real-life prescribing patterns. Int J COPD 2014; 9: 889-904.
9. Gottlieb V, Lyngsø AM, Sæbye D, Frølich A, Backer V. The use of COPD maintenance therapy following spirometry in General Practice. Eur Clin Respir J. 2016; 3: 10.
10. Reis AJ, Alves C, Furtado S, Ferreira J, Drummond M, Robalo-Cordeiro C. COPD exacerbations: management and hospital discharge. Pulmonology 2018; 24: 345-350.
11. Lopez-Campos JL, Navarrete BA, Soriano JB, et al. Determinants of medical prescriptions for COPD care: an analysis of the EPOCONSUL clinical audit. Int J Chron Obstruct Pulmon Dis 2018; 13: 2279-2288.
12. Mueller S, Wilke T, Bechtel B, Punekar YS, Mitzner K, Virchow JC. Non-persistence and non-adherence to long-acting COPD medication therapy: A retrospective cohort study based on a large German claims dataset. Respir Med 2017; 122: 1-11.
Published
2020-09-30
Section
INTERNAL MEDICINE - PEDIATRICS